// company-profile
Candel Therapeutics, Inc.
CADLExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings111Insiders17
// api This Candel Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Candel Therapeutics, Inc. insiders bought $34K across 3 transactions with no open-market sales.
- Most active insider: Manning Paul B with 1 transaction totaling $19K.
- Largest single purchase: $19K by Manning Paul B on Mar 31, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Candel Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$211.0M
QoQ change
+77.4%
Reporting period
2026-03-31
#1
FMR LLC
CIK 315066
$42.3M
8.6M shares
#2
RTW INVESTMENTS, LP
CIK 1493215
$31.5M
6.4M shares
#3
ACORN CAPITAL ADVISORS, LLC
CIK 2054410
$17.2M
3.5M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Loggia Nicoletta | CADL | Award | 779 | $4.11 | $3K |
| Mar 31, 2026 | PAPA JOSEPH C | CADL | Award | 2,795 | $4.11 | $11K |
| Mar 31, 2026 | Manning Paul B | CADL | Award | 4,618 | $4.11 | $19K |
| Feb 23, 2026 | Manning Paul B | CADL | Purchase | 550,458 | $5.45 | $3.00M |
| Jan 26, 2026 | Tak Paul Peter | CADL | Award | 629,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.